Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcus Biosciences (RCUS) Operating Leases: 2020-2021

Historic Operating Leases for Arcus Biosciences (RCUS) over the last 2 years, with Dec 2021 value amounting to $116.9 million.

  • Arcus Biosciences' Operating Leases rose 130.55% to $119.2 million in Q3 2022 from the same period last year, while for Sep 2022 it was $119.2 million, marking a year-over-year increase of 130.55%. This contributed to the annual value of $116.9 million for FY2021, which is 666.82% up from last year.
  • Latest data reveals that Arcus Biosciences reported Operating Leases of $116.9 million as of FY2021, which was up 666.82% from $15.2 million recorded in FY2020.
  • Over the past 5 years, Arcus Biosciences' Operating Leases peaked at $116.9 million during FY2021, and registered a low of $15.2 million during FY2020.
  • Over the past 2 years, Arcus Biosciences' median Operating Leases value was $66.1 million (recorded in 2020), while the average stood at $66.1 million.
  • Data for Arcus Biosciences' Operating Leases shows a peak YoY skyrocketed of 666.82% (in 2021) over the last 5 years.
  • Yearly analysis of 2 years shows Arcus Biosciences' Operating Leases stood at $15.2 million in 2020, then spiked by 666.82% to $116.9 million in 2021.